Literature DB >> 30338958

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations; Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

.   

Abstract

Entities:  

Year:  2018        PMID： 30338958

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

Review 1.  Therapeutic strategies of different HPV status in Head and Neck Squamous Cell Carcinoma.

Authors:  Yingming Sun; Zhe Wang; Sufang Qiu; Ruoyu Wang
Journal:  Int J Biol Sci       Date:  2021-03-10       Impact factor: 6.580
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.